Ozempic (Semaglutide) for Diabetes

Overview
Ozempic is a prescription drug approved by the Food and Drug Administration (FDA) to improve glycemic control in adults with type 2 diabetes. Ozempic is considered an adjunct treatment to diet and exercise. Ozempic is also referred to by its drug name, Semaglutide.

Ozempic is an incretin mimetic. Ozempic is also a glucagon-like peptide-1 (GLP-1) receptor agonist. Ozempic imitates the effects of incretin, which signals the pancreas to make more insulin and prevents the liver from releasing glucose.

How do I take it?
Prescribing information states that Ozempic should be administered via a subcutaneous injection once a week.

Ozempic comes in the form of a prefilled pen.

Side effects
The FDA-approved label for Ozempic lists common side effects including nausea, vomiting, diarrhea, abdominal pain, and constipation.

Rare but serious side effects listed for Ozempic include pancreatitis, kidney injury, low blood glucose, complications in people with diabetic retinopathy, and systemic allergic reactions.

For more details about this treatment, visit:

Ozempic.com – Novo Nordisk
https://www.ozempic.com/